Tepoxalin enhances the activity of an antioxidant, pyrrolidine dithiocarbamate, in attenuating tumor necrosis factor α-induced apoptosis in WEHI 164 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1465-1471

  Lee, Daniel H S ^a,b   Macintyre, J Philip ^a   Taylor, Gareth R ^a   Wang, Elizabeth ^a   Plante, Richard K ^a   Tam, Susanna S C ^a   Pope, Barbara L ^a   Lau, Catherine Y ^a  

^a R W Johnson Pharmaceutical Res I   (Canada)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PYRROLIDINE DITHIOCARBAMATE; RADICAL; TEPOXALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; APOPTOSIS; CLONE CELLS; DNA FRAGMENTATION; DRUG SYNERGISM; FIBROSARCOMA; MICE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZOLES; PYRROLIDINES; RECOMBINANT PROTEINS; THIOCARBAMATES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032995726     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Akama KT, Albanese C, Pestell RG and Van Eldik LJ (1998) Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc Natl Acad Sci USA 95:5795-5800.
2. Ameisen JC, Estaquier J, Idziorek T and De Bels F (1995) The relevance of apoptosis to AIDS pathogenesis. Trends Cell Biol 5:27-32.
3. Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME and Capetola RJ (1994) Tepoxalin: A dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent antiinflammatory activity and a favorable gastrointestinal profile. J Pharmacol Exp Ther 271:1127-1744.
4. Bersani L, Colotta F and Mantovani A (1986) Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells. Immunology 59:323-325.
5. Brekke O-L, Espevik T and Bjerve KS (1994) Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release. Lipids 29:91-102.
6. Buttke TM and Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15:7-10.
7. Coleman KG, Lyssikatos JP and Yang BV (1997) Chemical inhibitors of cyclin-dependent kinases. Annu Rep Med Chem 32:171-179.
8. Herberman RB and Holden HT (1978) Natural cell-mediated immunity. Adv Cancer Res 27:305-377.
9. Herrmann JL, Beham AW, Sarkiss M, Chiao PJ, Rands MT, Bruckheimer EM, Brisbay S and Mcdonnell TJ (1997) Bcl-2 suppresses apoptosis resulting from disruption of the NF-κB pathway. Exp Cell Res 237:101-109.
10. Higuchi M, Singh S, Chan H and Aggarwal BB (1995) Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-κB activation, cytotoxicity, and differentiation. Blood 86:2248-2256.
11. Hirose K, Longo DL, Oppenheim JJ and Matsushima K (1993) Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 7:361-368.
12. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL and Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
13. Huang Y-L, Shen CK-F, Luh T-Y, Yang HC, Hwang KC and Chou C-K (1998) Blockage of apoptotic signaling of transforming growth factor-β in human hepatoma cells by carboxyfullerene. Eur J Biochem 254:38-43.
14. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A and Jones DA (1998) Activation of caspase 3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 160:3480-3486.
15. Kazmi SMI, Plante RK, Visconti V, Taylor GR, Zhou L and Lau CY (1995) Suppression of NFκB activation and NFκB-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem 67:299-310.
16. Korsmeyer SJ (1995) Regulators of cell death. Trends Genet 11:101-105.
17. Kroemer G (1998) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620.
18. Kumar A, Commane M, Flickinger TW, Horvath CM and Stark GR (1997) Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science (Wash) 278:1630-1632.
19. Lee DHS, Tam SSC, Wang E, Taylor GR, Plante RK and Lau CY (1996) The NF-κB inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b/CD18 and CD106. Immunol Lett 53:109-113.
20. Mattson MP (1998) Free radicals, calcium, and the synaptic plasticity-cell death continuum: Emerging roles of the transcription factor NFκB. Int Rev Neurobiol 42:103-168.
21. Metodiewa D, Skolimowski J, Kochman A, Gwozdzinski K and Glebska J (1998) Tempicol-2 (4-hydroxy-4-(2-picolyl)-2,2,6)6-tetramethylpiperidine-1-oxyl), a stable free radical, is a novel member of nitroxide class of antioxidants and anticancer agents. Anticancer Res 18:369-377.
22. 2 synthases. Chem Biol 2:243-350.
23. Munroe DG, Wang YE, MacIntyre JP, Tam SSC, Lee DHS, Taylor GR, Zhou L, Plante KR, Kazmi SMI, Bauerle PA and Lau CY (1995) Novel intracellular signaling function of prostaglandin H synthase-1 in NF-κB activation. J Inflamm 45:260-268.
24. Nemeth K, Bugovics G and Szekely JI (1997) Antiapoptotic effect of benzloxycarbonyl-aspartyl-(β-tertier-butyl ester)-bromomethylketone (Z-D(OtBu)-Bmk), an intermediate of interleukin-1 β converting enzyme inhibitors. Int J Immunopharmacol 19:215-225.
25. Powis G, Briehl M and Oblong J (1995) Redox signaling and the control of cell growth and death. Pharmacol Ther 68:149-173.
26. Sandstrom PA, Tebbey PW, Van Cleave S and Buttke TM (1994) Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. J Biol Chem 269:798-801.
27. Schreck R, Albermann K and Baeuerle PA (1992) Nuclear factor κB: An oxidative stress-responee transcription factor of eukaryotic cells (a review). Free Radical Res Commun 17: 221-237.
28. Srinivasan A, Li F, Wong A, Kodandapani L, Smidt R Jr, Krebs J, Fritz LC, Wu J and Tomaselli KJ (1998) Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem 273:4523-4529.
29. Suffys P, Beyaert R, Van Roy F and Fiers F (1987) Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem Biophys Res Commun 149:735-743.
30. Tam SSC, Lee DHS, Wang EY, Munroe DG and Lau CY (1995) Tepoxalin, a novel dual inhibitor of the prostaglandin-H-synthase cyclooxygenase and peroxidase activities. J Biol Chem 270:13948-13955.
31. Vanderhoek JY and Lands WEM (1973) The inhibition of the fatty acid oxygenase of sheep vesicular gland by antioxidants. Biochim Biophys Acta 296:382-385.
32. Vaux DL and Strasser A (1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239-2244.
33. Van Antwerp DJ, Martin SJ, Verma IM and Green DR (1998) Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol 8:107-111.
34. Veis DJ, Sorenson CM, Shutter JR and Korsmeyer SJ (1993) Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
35. Wang C-Y, Mayo MW and Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science (Wash) 274:784-787.
36. Wood KA and Youle RJ (1994) Apoptosis and free radicals. Ann NY Acad Sci 738:400-407.
37. Zhou L, Ritchie D, Wang EY, Barbone AG, Argentierl D and Lau CY (1994) Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A. J Immunol 153:5026-5037.